Bloom Energy’s $20 Billion Backlog Faces Its First Earnings Test

A major institutional bet on Bloom Energy highlights fuel cells as a key solution for AI's power needs, with a $20B backlog and Oracle partnership driving growth.

A single institutional investor just scooped up 22.9 million Class A shares in Bloom Energy. That is not a casual bet — it is a vote of confidence in fuel cells as the answer to AI’s insatiable electricity demand. The question now is whether the company’s soaring stock price can survive its own success.

The Oracle Engine

The centerpiece of Bloom’s growth story is its partnership with Oracle. The cloud giant has ordered fuel cell systems capable of delivering up to 2.8 gigawatts of power, with 1.2 gigawatts already under contract. Oracle intends to use the technology to keep its AI data centers humming with stable, on-site electricity.

The relationship goes deeper than a supply agreement. Oracle also holds warrants on roughly 3.5 million Bloom shares at an exercise price of $113.28, valid through October 2026. That structure gives Oracle a direct financial interest in Bloom’s stock performance — not just its power output.

Speed as a Competitive Moat

Traditional power grids are buckling under the weight of AI infrastructure expansion. In regions like Northern Virginia, connecting a new facility can take years. Bloom’s solid-oxide fuel cells, built on 800-volt DC architectures, bypass that bottleneck entirely. The company can install its on-site systems in 55 to 90 days — a timeline that data center operators find increasingly attractive.

To meet the surge in demand, Bloom is aggressively scaling production. By the end of 2026, annual manufacturing capacity is expected to double to two gigawatts. A financing partnership with Brookfield provides $5 billion to help customers deploy the technology at scale. The company is also leveraging its fuel cells for hydrogen production, combining industrial waste heat to achieve high efficiency.

A Backlog That Demands Delivery

The order book stands at $20 billion — $6 billion from product sales and the remainder from long-term service contracts. That backlog is the bedrock of management’s 2026 revenue target of $3.1 billion to $3.3 billion, up from $2.02 billion in fiscal 2025, when sales grew 37%.

On Tuesday after the US market close, Bloom will report first-quarter results. Analysts expect earnings per share of $0.13 on revenue of roughly $531 million. For the full year, management guides for adjusted EPS between $1.33 and $1.48. The quarterly report will offer the first glimpse of whether recent large orders are already flowing through to the bottom line.

Analyst Divergence, Market Caution

The stock closed Monday at $231.17, down 2.7% — a modest pullback after a nearly 78% surge over the past month. That rally has split the analyst community.

UBS raised its price target to $251 with a buy rating. Citigroup lifted its target to $229 but remains neutral. JPMorgan set a target of $231 with an overweight rating. Baird rates the stock outperform with a $242 target, citing expected revenue acceleration through the year.

Skeptics point to the valuation. At roughly 165 times forward earnings, Bloom trades at a massive premium to the sector. A market capitalization near $54 billion leaves little room for error. The $20 billion backlog must now prove that institutional interest can translate into sustainable profits — and that the stock’s breathtaking run has a foundation that can withstand the scrutiny of earnings season.